US Patent Issued to OncoTherapy Science on Sept. 29 for "FOXM1-derived peptide, and vaccine including same" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,265, issued on Sept. 29, was assigned to OncoTherapy Science Inc. (Kawasaki, Japan).

"FOXM1-derived peptide, and vaccine including same" was invented by Sachiko Yamashita (Kawasaki, Japan) and Tetsuro Hikichi (Kawasaki, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides FOXM1-derived epitope peptides having the ability to induce cytotoxic T cells. The present invention further provides polynucleotides encoding the peptides, antigen-presenting cells presenting the peptides, and cytotoxic T cells targeting the peptides, as well as methods of inducing the antigen-presenting cells or CTLs. The present invention also pro...